While patient genomic data suggests GATA3 mutations as cancer drivers, the functional consequences of GATA3 mutations in breast cancer are underexplored (Adomas et al., 2014; Mair et al., 2016; Gustin et al., 2017; Emmanuel et al., 2018; Takaku et al., 2018). This evidence concerns the gene GATA3 and breast cancer.